There is one biggest difference between private financing and secondary market financing, that is, the degree of supervision, listed companies have strict procedures, and private financing companies have not yet been listed, so the procedure requires investors to pay more attention.
On Monday the 25th, Lei Hao sent Lan Shijie and Zhao Lichen back to Yangcheng to reduce positions and arbitrage of Nanyang Mining, while he took a group of people to Danghe Pharmaceutical in Su City, Suzhou Province, intending to stay here for a period of time and complete the work at this stage.
The contract has been signed, the procedures have been completed, and now Lei Hao only needs to inject funds into the designated account, and the project team he controls will become the major shareholder of Danghe Pharmaceutical, and he personally holds 5 stock options, which is definitely a big man in this small pharmaceutical company.
What made Lei Hao unaccustomed was that as the scale of the assets he came into contact with and mastered gradually increased, Qiu Yuting didn't know what he was thinking, so he stuffed two bodyguards beside him.
"Brother Zheng and Brother Bu, not to mention the strength for the time being, it looks like a panache to take it with you," just got off the plane, Lei Hao looked at the two bodyguards standing beside him, and complained in his heart: "It's just that the name is too pitiful, Zheng Yimao can't make a dime of cloth and rise to the top."
Lei Hao was born in poverty, although he was not used to the two bodyguards that Qiu Yuting stuffed over, but he had already explained something if he didn't refuse, that is, bringing bodyguards would have more face.
Getting off the plane, the bodyguards opened the way along the way, Lei Hao was ruthlessly vain, and after seeing the personnel who came to pick up Danghe Pharmaceutical, he immediately put away his naivety and put on a serious face.
"Welcome, on behalf of all the staff of Danghe Pharmaceutical, I would like to welcome Mr.
Lei to visit the company."
Kong Weixue, the general manager with no limits, personally led the team to pick up the plane, which showed the importance that Danghe Pharmaceutical attached to Lei Hao and his party.
As the general manager and shareholder, Kong Weixue is not a small person in Danghe Pharmaceutical, and the specifications of the pick-up are naturally not much lower.
"See you again, hello Mr.
Kong."
After the contract was signed, Lei Hao didn't have to show his acting skills anymore, showing his true face, and talked about work with Kong Weixue while walking: "Our project team will send a financial staff to the company, according to the contract."
"No problem, Danghe Pharmaceutical welcomes Mr.
Lei's decision, and we will do a good job of cooperating."
This was the way it should be, and Kong Weixue quickly agreed to Lei Hao's series of requests.
After getting into the car, Kong Weixue smiled and said: "Mr.
Lei came by coincidence, because the financial problem has been solved, the laboratory will screen the compounds that have been made in the next few days, as long as the active compounds appear to reach the expected quantity, your investment will not be lost." ” "Then I wish us a fortune together."
After Lei Hao answered, he leaned back on the saddle and rested, but he was thinking about the problem in his heart.
With an investment of 40 million plus 5 stock options, the success of Danghe Pharmaceutical directly determines Lei Hao's profit and loss, and he certainly knows the company's focus at this stage.
According to the data in the undergraduate textbook, each new drug costs hundreds of millions of dollars on average from the source to phase 3 clinical trials, and the valuation of Danghe Pharmaceutical is only more than 50 million if converted into dollars.
Small pharmaceutical companies like Danghe Pharmaceutical are not able to complete the development of new drugs independently, they will only conduct preclinical research, and sell the research when the results are produced, and the preclinical research is about 4 steps The first step is to determine the drug target, that is, what you want to study, the second step is to synthesize the compound, the third step is to screen out the active compound from the synthesized compound, and the fourth step is to conduct drug evaluation, that is, to conduct animal experiments or something, and after completion, you can sell it.
Danghe Pharmaceutical currently has four compounds, and from the evaluation report, it is expected that two compounds can pass the final screening, and when the project is sold, everyone will sit on the ground and share the spoils, and then select the next project for research.
Lei Hao represents profit-seeking capital, so he will not care about the next project, and when the experiment is successful, he will definitely change the shares, and I believe that it will be absolutely sought-after at that time.
Surprisingly, Lei Hao waited for two days, and by Wednesday the 27th, what he got was that the experiment was not going well, and it was predicted that there was only one compound that could pass the experiment in the end, and there might not even be one.
Lei Hao was dumbfounded for a moment, he had already invested 40 million real money in it on Tuesday, and now what kind of experiment is not going well Is this funny to say that it will be doubled "Mr.
Lei, it's here."
On the afternoon of the 27th, because the experiment was not going well, Danghe Pharmaceutical held a board meeting to prepare to make a decision, and Lei Hao was also fortunate to attend his first board meeting.
According to the regulations of Danghe Pharmaceutical, natural persons and legal persons holding more than 10 shares automatically become members of the board of directors, and the Thunder No. 1 project team just meets this standard, as the actual person in charge of the project, Lei Hao is also qualified to represent Thunder No. 1 to participate in the meeting.
It's just that the meeting that will sit on the ground and share the spoils will turn into a negotiation and dumping the pot, and Lei Hao couldn't cry or laugh in his heart.
"Okay, before we get to the formal meeting, let's welcome the new director, Mr.
Lei Haolei."
At 16 o'clock, the chairman of Danghe Pharmaceutical said on the rostrum of the conference room: "Mr.
Lei's asset management plan is expected to have an annual return of more than 200, which can be said to be a famous God of Wealth in the securities industry." ” The people who can participate in the board of directors are not poor people, and they have not contacted Lei Hao in the past two days, in order to build a relationship, maybe they will have the opportunity to make a fortune together in the future.
Standing up and being hypocritical with these people, when Lei Hao sat back, his eyes stayed on a middle-aged and elderly man with a wry smile on the corner of his mouth.
If that person didn't say his age, the white hair on his head might be mistaken for being over the age of six, but Lei Hao had read his information and knew that the other party was actually only fifty-one years old, and he was currently in charge of the research and laboratory of Danghe Pharmaceutical, and his name was Li Miantang.
If it is said that the turnaround of Danghe Pharmaceutical may be in anyone, Lei Hao will definitely vote for Li Miantang, who is a well-known scholar in China, and his reputation and ability are also well-known, but there is still some gap from the top of the pyramid.
As Lei Hao expected, the directors also knew who should speak the most at this time, and less than five minutes after the meeting began, Li Miantang stood up to speak.
"The success of drug development is a probabilistic event, including all its processes, if it is not successful, it will not even have a chance to become a step, a few days ago, our research and development is progressing smoothly" "Even if the remaining active compound is made of a drug, the possibility of entering clinical trials is very low, and its cost and efficacy are destined to have a poor market prospect, so" From the beginning to the current progress, after Li Miantang finished talking about everything, there was an inexplicable brilliance in his eyes, and he said in a sincere tone: "I want to apply for experiments on compounds 03, 05 and 07, and I believe that the probability of a good result will not be too low." ” The conference room suddenly resounded with some head-to-ear discussions, including Lei Hao, everyone knew the reason why these three compounds were abandoned, that is, the cost.
The market for antihypertensive drugs is indeed large, but the price has been placed there, and the high cost of the compound you develop proves that the cost of the drug is high, so what is the value of how to sell the experiment needs money, and the goal of capital is always to chase profits, and who will play with you if you don't have money Capital makes dreams come true, provided that your dreams can create value for capital.
Looking at the brilliance in Li Miantang's eyes, Lei Hao seemed to see countless gold ingots beckoning
.
: